about
The role of cardiovascular magnetic resonance in the assessment of severe aortic stenosis and in post-procedural evaluation following transcatheter aortic valve implantation and surgical aortic valve replacement.The appropriate and justified use of medical radiation in cardiovascular imaging: a position document of the ESC Associations of Cardiovascular Imaging, Percutaneous Cardiovascular Interventions and ElectrophysiologyNormal values for cardiovascular magnetic resonance in adults and childrenCardiac T1 Mapping and Extracellular Volume (ECV) in clinical practice: a comprehensive reviewQuantification of LV function and mass by cardiovascular magnetic resonance: multi-center variability and consensus contours.Assessment of stable coronary artery disease by cardiovascular magnetic resonance imaging: Current and emerging techniques.Simplifying cardiovascular magnetic resonance pulse sequence terminology.Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) board of trustees task force on standardized post processing.Coronary Artery Disease Evaluation in Rheumatoid Arthritis (CADERA): study protocol for a randomized controlled trial.Measurement of left ventricular dimensions with contrast-enhanced three-dimensional cine imaging facilitated by k-t SENSE.Cost-effectiveness of cardiovascular magnetic resonance in the diagnosis of coronary heart disease: an economic evaluation using data from the CE-MARC study.Imaging in population science: cardiovascular magnetic resonance in 100,000 participants of UK Biobank - rationale, challenges and approachesCine MRI using steady state free precession in the radial long axis orientation is a fast accurate method for obtaining volumetric data of the left ventricle.Myocardial strain and symptom severity in severe aortic stenosis: insights from cardiovascular magnetic resonance.Myocardial T1 mapping: application to patients with acute and chronic myocardial infarction.Assessment of ischaemic burden in angiographic three-vessel coronary artery disease with high-resolution myocardial perfusion cardiovascular magnetic resonance imaging.The distribution and prognosis of anomalous coronary arteries identified by cardiovascular magnetic resonance: 15 year experience from two tertiary centresPhysiology of Angina and Its Alleviation With Nitroglycerin: Insights From Invasive Catheter Laboratory Measurements During Exercise.Relationship of dysglycemia to acute myocardial infarct size and cardiovascular outcome as determined by cardiovascular magnetic resonance.Reference values for healthy human myocardium using a T1 mapping methodology: results from the International T1 Multicenter cardiovascular magnetic resonance study.Susceptibility-weighted cardiovascular magnetic resonance in comparison to T2 and T2 star imaging for detection of intramyocardial hemorrhage following acute myocardial infarction at 3 Tesla.Established and emerging cardiovascular magnetic resonance techniques for the assessment of stable coronary heart disease and acute coronary syndromesThe microvascular effects of insulin resistance and diabetes on cardiac structure, function, and perfusion: a cardiovascular magnetic resonance study.Three-dimensional balanced steady state free precession myocardial perfusion cardiovascular magnetic resonance at 3T using dual-source parallel RF transmission: initial experienceDiagnosis of arrhythmogenic right ventricular dysplasia: a review.Rationale and design of the Clinical Evaluation of Magnetic Resonance Imaging in Coronary heart disease 2 trial (CE-MARC 2): a prospective, multicenter, randomized trial of diagnostic strategies in suspected coronary heart disease.MR imaging of cardiac tumors and masses: a review of methods and clinical applications.Pharmacokinetic modeling of delayed gadolinium enhancement in the myocardium.Quantification of myocardial blood flow with cardiovascular magnetic resonance throughout the cardiac cycleSingle bolus versus split dose gadolinium administration in extra-cellular volume calculation at 3 Tesla.Timing of cardiovascular MR imaging after acute myocardial infarction: effect on estimates of infarct characteristics and prediction of late ventricular remodeling.Clinical evaluation of magnetic resonance imaging in coronary heart disease: the CE-MARC study.Comparison of the Diagnostic Performance of Four Quantitative Myocardial Perfusion Estimation Methods Used in Cardiac MR Imaging: CE-MARC SubstudyConstruction and validation of anisotropic and orthotropic ventricular geometries for quantitative predictive cardiac electrophysiologyCardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial.The Coumadin Ridge: An Important Example of a Left Atrial Pseudotumour demonstrated by Cardiovascular Magnetic Resonance ImagingIndividual component analysis of the multi-parametric cardiovascular magnetic resonance protocol in the CE-MARC trialCardiovascular magnetic resonance of myocardial edema using a short inversion time inversion recovery (STIR) black-blood technique: diagnostic accuracy of visual and semi-quantitative assessment.Coronary MR angiography at 3T: fat suppression versus water-fat separationThe effect of changes to MOLLI scheme on T1 mapping and extra cellular volume calculation in healthy volunteers with 3 tesla cardiovascular magnetic resonance imaging.
P50
Q26739737-3B2866E1-0F1B-47BB-8F8F-33BB77452A8CQ26827546-E90F5E05-DED7-4519-BC47-95F9DF3B6873Q26998833-DAFFA3F6-CB13-4B9B-A069-3236AC37F5A3Q28078687-2ABAE8E1-4FDC-47EF-A29B-CE594EE8F007Q30278953-1F661F17-1E81-450A-BE89-77ECCFE4658EQ30361261-6C08F192-B613-434C-82D8-89C2836249ABQ30408820-C70880B6-2E80-4443-BC3B-BA4809E443E3Q30418614-90B18588-825E-4ED9-AACF-C2BE5FF7D26EQ30426026-FCE8D154-56B8-49A3-B744-A748321BB6D4Q30482404-5F644B0F-15CD-4319-9F5D-86646299D42EQ30617433-58E46973-9A14-4FD2-AB93-272575DF2F7EQ30634750-2DC98429-CAE9-4654-80F2-1D4D91A7291BQ30667099-3897F708-EE3C-4B73-9C42-55F07C3FF7C9Q33168370-215468F3-8114-46CE-BF79-551B4C4855F1Q33292067-38D9753E-3651-4378-A993-9572B1CEAC1EQ33627699-C7B267D3-8B6F-41F3-A3EA-C4FE54EA0F71Q33687190-E9249CAC-29D6-4E50-ADAE-8CA25AE34B4DQ33853633-4154B1AC-6795-4FA7-9690-BA868B3D5B8BQ34322273-5AA15613-045E-40E0-89F9-E4FE5EEDA0F7Q34374909-E324CF20-5A88-40D0-9BDE-3E65C3395B26Q34410239-8A4B82D8-41CE-4367-BC0B-424F59C7A74FQ34422721-CA09F722-B7FC-4327-AD78-610BC323804FQ34556389-8A5A6387-E900-4963-8DDB-38FBBC622410Q34584697-5723816F-2021-4051-AA17-6A4BC8D1117EQ34634908-4BF00D0F-C942-4574-B231-64EAC31F1D4FQ34776019-4ADCCD49-691E-4FB2-A867-E4B0253F3AECQ34781641-177CF59E-0DBE-4F00-82E1-0EB2C893969FQ34886114-5412812D-62F4-4955-B8B8-4AF03FE44AFCQ35021302-31825900-2DBC-496D-B4D5-E0AAF26BB2D1Q35030258-E3F09A77-3B74-4AA2-8DFD-21BB6166FA8DQ35249522-01FCE52E-4C30-4132-AEAF-98D45DEA0AC6Q35575404-8F71E087-253F-4F57-BCC4-E51C198A6C8AQ35683420-9243CEEA-9CAE-48C0-9A3F-9223CD8FBA1AQ35683704-8E1AAD21-A045-4089-9685-871D65C9C8E8Q35740419-B10D8E5A-07BD-4DBE-B597-E81639712F5BQ35828955-BBC8CE4F-9CA0-4862-98B8-BCC371F54D6EQ35853638-C29B72F7-F040-4F5D-BF37-41D006C3E8DAQ35953519-EAA15FEC-726A-47CB-A79F-3C4D1F9884D7Q35977929-E9A6E4E1-A570-420E-81F2-6BDF838C8250Q36027612-7CA51A4D-36DA-453A-B49E-96A0A4FE2501
P50
description
hulumtues
@sq
researcher
@en
researcher
@en-gb
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Sven Plein
@ast
Sven Plein
@cy
Sven Plein
@en
Sven Plein
@en-gb
Sven Plein
@es
Sven Plein
@la
Sven Plein
@nl
Sven Plein
@sl
type
label
Sven Plein
@ast
Sven Plein
@cy
Sven Plein
@en
Sven Plein
@en-gb
Sven Plein
@es
Sven Plein
@la
Sven Plein
@nl
Sven Plein
@sl
prefLabel
Sven Plein
@ast
Sven Plein
@cy
Sven Plein
@en
Sven Plein
@en-gb
Sven Plein
@es
Sven Plein
@la
Sven Plein
@nl
Sven Plein
@sl
P185
P214
P106
P1153
6701840061
P185
P2031
2000-01-01T00:00:00Z
P21
P214
P31
P496
0000-0002-0997-4384
P6178
01372003105.40
P734
P735
P7859
lccn-nb2011002022